It solved the problem I had with reagent degradation, allowing for more consistent results across my experiments
BPC-157 prevented catalepsy development when given before reserpine and reversed established catalepsy when administered 24 hours after vesicle depletion
Problem: no noticeable effects after 4 weeks at 2mg This is actually normal
If you have an active injury or condition, we may advise that you follow your doctors treatment plan and can discuss whether BPC-157 is an appropriate complement
BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide that operates through nitric oxide system modulation, growth factor upregulation (VEGF, FGF, EGF), and FAK-paxillin pathway activation
: BPC-157 , , : - ( , , )